Our results are alsoconsistent with the SAPiT and STRIDE results, which found that cART initiation after2–4 wk improved survival or AIDS-free survival compared to initiation at8–12 wk only among individuals with severe immune suppression (i.e., CD4 cellcounts≤50 cells/μl) [18],[19]. The gene discussed is CD4; the disease is AIDS.